Literature DB >> 12706270

Immunosuppressive (FK506) and non-immunosuppressive (GPI1046) immunophilin ligands activate neurotrophic factors in the mouse brain.

Ken-ichi Tanaka1, Naoko Fujita, Norio Ogawa.   

Abstract

Based on the fact that several recent reports have indicated that non-immunosuppressive immunophilin ligands (IPLs) can activate neurite outgrowth or nerve regeneration, we investigated the neurotrophic factor-activating abilities of IPLs in vivo in order to clarify the molecular basis of neurotrophic-like activity. Both FK506 (an immunosuppressive IPL) and GPI1046 (a non-immunosuppressive IPL) significantly increased glial cell line-derived neurotrophic factor (GDNF) content in the substantia nigra. In addition, FK506 increased striatal brain-derived neurotrophic factor (BDNF) content significantly. Thus, our present results suggest that the molecular basis of IPL-induced neurotrophic-like activity may be dependent on GDNF and/or BDNF activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706270     DOI: 10.1016/s0006-8993(03)02434-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  A multiplexed proteomics approach to differentiate neurite outgrowth patterns.

Authors:  Tong Liu; Veera D'mello; Longwen Deng; Jun Hu; Michael Ricardo; Sanqiang Pan; Xiaodong Lu; Scott Wadsworth; John Siekierka; Raymond Birge; Hong Li
Journal:  J Neurosci Methods       Date:  2006-06-23       Impact factor: 2.390

Review 2.  Pathogenesis-targeted, disease-modifying therapies in Parkinson disease.

Authors:  Amaal AlDakheel; Lorraine V Kalia; Anthony E Lang
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

3.  Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats.

Authors:  Y Sari; S N Sreemantula
Journal:  Neuroscience       Date:  2012-10-08       Impact factor: 3.590

Review 4.  Targets for neuroprotection in Parkinson's disease.

Authors:  Talene A Yacoubian; David G Standaert
Journal:  Biochim Biophys Acta       Date:  2008-10-01

Review 5.  Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection.

Authors:  Eero Castrén
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

Review 6.  Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.

Authors:  Sumit Sarkar; James Raymick; Syed Imam
Journal:  Int J Mol Sci       Date:  2016-06-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.